Financial Updates and Promising Developments in Biotech and Mining Sectors

Intensity Therapeutics, Inc. secures $6.6 million for clinical trials, Trilogy Metals Inc. positions itself as a key player in the mining industry, a study explores EV battery reuse vs. recycling, and NRx Pharmaceuticals, Inc. petitions FDA for a ban on Benzethonium Chloride in ketamine products, focusing on developing safer therapeutics.